Skip to main content
. 2020 Apr 23;8(2):194. doi: 10.3390/vaccines8020194
cCMV congenital Cytomegalovirus
HCMV human cytomegalovirus
PI primary infection
T transmitting women
NAb neutralizing antibodies
NT non-transmitting women
HIG human immunoglobulin
gCs glycoprotein complexes
PC pentamer complex
mAbs monoclonal antibodies
IMAB inhibition of monoclonal antibody binding
PFI plaque formation inhibition
LTI leukocyte transfer inhibition
SFI syncytium formation inhibition
ELISPOT assay enzyme-linked immunospot assay
CID cytomegalic inclusion disease
SNHL sensoryneural hearing loss
TC trimer complex
HPC hemopoietic progenitor cells
EBV Epstein-Barr virus
IE immediate-early
UL unique long region
BAC bacterial artificial chromosome
US unique short region
SNP single nucleotide polymorphism
ADCC antibody-dependent cellular cytotoxicity
ADCP antibody-dependent cellular phagocytosis;
ADCD antibody-dependent complement deposition
LPR lymphoproliferative response
DB dense bodies
MVA modified vaccinia virus Ankara
SOT solid-organ transplant
HSCT hematopoietic stem cell transplant
CTB cytotrophoblasts
STB syncytiotrophoblasts
FV floating villi
AV anchoring villi